Scholarly Index
Claude B. Sirlin
University of California San Diego; 59,742 total citations; 648 total publications; best world rank #13
University of California San Diego
59,742Total citations
648Total publications
126H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 13 | US 8 | 99.89 |
| Liver Disease Diagnosis and Treatment | Lifetime | 37 | US 15 | 99.91 |
| Liver Disease and Transplantation | Lifetime | 85 | US 32 | 99.68 |
| MRI in cancer diagnosis | Lifetime | 65 | US 34 | 99.36 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 310 | US 137 | 98.91 |
| Cardiovascular Disease and Adiposity | Lifetime | 248 | US 129 | 98.63 |
| Advanced MRI Techniques and Applications | Lifetime | 781 | US 369 | 98.27 |
| Liver Diseases and Immunity | Lifetime | 204 | US 62 | 98.26 |
| Abdominal Trauma and Injuries | Lifetime | 307 | US 180 | 96.14 |
| Pelvic and Acetabular Injuries | Lifetime | 926 | US 467 | 95.61 |
| Omental and Epiploic Conditions | Lifetime | 47 | US 22 | 83.47 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 148 | US 42 | 99.20 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 85 | US 20 | 98.77 |
| MRI in cancer diagnosis | 2021-2025 | 148 | US 36 | 94.82 |
| Liver Disease and Transplantation | 2021-2025 | 441 | US 125 | 95.69 |
| Liver Diseases and Immunity | 2021-2025 | 250 | US 66 | 91.44 |
| Hepatitis B Virus Studies | 2021-2025 | 982 | US 206 | 87.04 |